mcIRBP-19 (Bitter Melon Peptide)
mcIRBP-19 (Bitter Melon Peptide) is a weight management peptide used in evidence-based, physician-supervised protocols. Use for post-prandial glucose management, insulin resistance, or as adjunct to GLP-1 therapy for glycemic control.
What is mcIRBP-19 (Bitter Melon Peptide)?
Plant-derived 19-AA insulin receptor-binding peptide from bitter melon (Momordica charantia). Binds insulin receptor, potentiates post-prandial glucose uptake, reduces glycemic spikes. FDA NDI-accepted. Inject before largest meal for peak effect.
Uses & clinical decision logic
Use for post-prandial glucose management, insulin resistance, or as adjunct to GLP-1 therapy for glycemic control.
mcIRBP-19 (Bitter Melon Peptide) dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 2mL | 500mcg-1mg | 20-40 units | Daily (5 on / 2 off) | SubQ |
Safety & contraindications
Monitor glucose — may lower post-prandial glucose significantly; adjust if on insulin.
Stacking & combinations
Synergistic with MOTS-c for AMPK activation; pairs with Berberine and Chromium.
Related peptides
Frequently asked questions
What is mcIRBP-19 (Bitter Melon Peptide) used for?
Use for post-prandial glucose management, insulin resistance, or as adjunct to GLP-1 therapy for glycemic control.
What is the typical mcIRBP-19 (Bitter Melon Peptide) dosage?
Common dosing ranges from 500mcg-1mg (Daily (5 on / 2 off), SubQ). Exact dosing is individualized and set by a licensed physician.
How is mcIRBP-19 (Bitter Melon Peptide) administered?
mcIRBP-19 (Bitter Melon Peptide) is typically administered via SubQ.
What are the contraindications for mcIRBP-19 (Bitter Melon Peptide)?
Monitor glucose — may lower post-prandial glucose significantly; adjust if on insulin.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.